Lv51
930 积分 2023-11-14 加入
First-in-Human Study on Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Escalating Doses of HEC88473, a Novel Dual GLP-1 and FGF21 Receptor Agonist in Healthy and Obese Chinese Subjects
17天前
已完结
A multicenter, randomized, double-blinded, placebo-controlled, phase Ⅲ study evaluating the efficacy and safety of Xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
30天前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, placebo-controlled phase 3 trial
30天前
已完结
Glucocorticoids increase CD4+CD25highcell percentage and Foxp3 expression in patients with multiple sclerosis
1个月前
已完结
Dose effect of corticosteroids on peripheral lymphocyte profiles in patients with systemic lupus erythematosus
1个月前
已完结
Myostatin Knockout in Mice Increases Myogenesis and Decreases Adipogenesis
1个月前
已完结
Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
1个月前
已完结
Changes in Muscle Myostatin Expression in Obese Subjects after Weight Loss
1个月前
已完结
Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial
1个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2个月前
已完结
皖公网安备34019202002308
